Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Medical Devices

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Second U.S. Virus Wave Emerges With Texas Hitting Record

<< Previous

Bullboard Posts

Next >>

Comment by Smiles62on Jun 11, 2020 9:45am

97 Views

Post# 31138031

RE:RE:RE:RE:Second U.S. Virus Wave Emerges With Texas Hitting Record

Again from their website, April 7
The exercise price of the Warrants will be at a 25% premium over the market price at the time of issuance and have a term of three years. Further, the Warrants will also contain a provision for accelerated expiry should Lattice Biologics’ Shares trade on the TSX-V, for a period of 10 consecutive trading days, at a premium of at least 200% above the warrant exercise price.

does this mean if they draw at 0.05, the warrants that alumina get are priced at a gain of 25%, in other words 0.037? Anyone, understand this accountant gibberish?

If that is the case, then we know Alumina holds tons of stock already and pressuring the stock price at a minimum so they can rip us all off.
Again, I'm not sure I understand...

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features